Regarding the relevance of the APP/PS1 transgenic mouse as an experimental AD model, a previous study showed that impaired glucose tolerance and reduced insulin sensitivity precede amyloid plaque deposition and cognitive decline in these mice (Macklin et al., 2017). The gene discussed is PSEN1; the disease is amyloidosis.